Curated Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Buy
+67,975
New +$5.48M 0.04% 424
2023
Q3
Sell
-2,324
Closed -$205K 142
2023
Q2
$205K Buy
+2,324
New +$200K 0.04% 131
2022
Q3
Sell
-2,381
Closed -$215K 131
2022
Q2
$215K Sell
2,381
-1,747
-42% -$177K 0.06% 118
2022
Q1
$427K Hold
4,128
0.14% 85
2021
Q4
$427K Sell
4,128
-339
-8% -$39.3K 0.14% 88
2021
Q3
$560K Buy
4,467
+34
+0.8% +$4.4K 0.31% 64
2021
Q2
$550K Buy
4,433
+435
+11% +$54.6K 0.3% 65
2021
Q1
$472K Sell
3,998
-398
-9% -$46.6K 0.29% 70
2020
Q4
$515K Buy
+4,396
New +$484K 0.33% 57

Other funds holding MDT

Curated Wealth Partners's MDT Position: Q2 2026 in Review

Curated Wealth Partners opened a new position in Medtronic (MDT) in Q2 2026: 67,975 shares worth $289K. The stake represents 0.04% of the portfolio and ranks #424 among its holdings. This is a return to the name: Curated Wealth Partners previously reported a position in MDT as recently as Q2 2023.

Curated Wealth Partners first reported a position in MDT in Q4 2020 and has held it in 9 quarters since. The position peaked at $560K in Q3 2021. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Curated Wealth Partners held 67,975 shares of Medtronic worth $289K as of Q2 2026.
  • Medtronic was a new Curated Wealth Partners position in Q2 2026.
  • Medtronic made up 0.04% of Curated Wealth Partners's portfolio in Q2 2026, its #424 holding.
  • Curated Wealth Partners first reported a position in Medtronic in Q4 2020 and has held it in 9 quarters since.
  • Curated Wealth Partners's Medtronic position peaked at $560K in Q3 2021.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.